vivomixx
Cell therapyexperimental
Clinical trial activity
15 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02768818)
Timeline
Indications
Studied for
- Behavior, Addictive · Phase 3
- Breast Neoplasms · Phase 1/Phase 2
- Congenital Microtia · Phase 2
- Diabetes Mellitus · Phase 3
- Diet Therapy · Phase 3
- Dysbiosis · Phase 2
- Growth Disorders · Phase 2
- Hyperbilirubinemia, Neonatal · Phase 2
- Jaundice, Neonatal · Phase 2
- Mental Disorders · Phase 2
- Osteoporosis · Phase 1/Phase 2
- Pregnancy Complications · Phase 2
- Pregnancy, High-Risk · Phase 3
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vivomixx
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06087874 | Phase 2 | Jan 31, 2024 | Chinese University of Hong Kong |
| NCT05920018 | N/A | Oct 2, 2023 | University of Munster |
| NCT05922683 | Phase 2 | Jul 1, 2023 | Aga Khan University, Bill and Melinda Gates Foundation, Institut Pasteur, International Center for Diarrheal Disease Research, University of Zambia |
| NCT06196450 | Phase 2 | Jun 22, 2023 | Bill and Melinda Gates Foundation, International Center for Diarrheal Disease Research |
| NCT04243148 | N/A | Feb 29, 2020 | University of Barcelona |
| NCT04175223 | N/A | Nov 15, 2019 | University of Nice Sophia Antipolis |
| NCT03906578 | N/A | May 1, 2019 | Humboldt University |
| NCT04099433 | N/A | Mar 1, 2019 | University of Roma La Sapienza |
| NCT03518268 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2018 | Perrigo, Tel Aviv University |
| NCT03109587 | N/A | Jun 1, 2018 | University of Washington |
| NCT03478527 | N/A | Jan 8, 2018 | University of Hamburg |
| NCT03369431 | N/A | Dec 13, 2017 | University of London |
| NCT03236090 | N/A | Jul 15, 2017 | Spanish Clinical Research Network, University of Barcelona |
| NCT03860415 | N/A | Feb 1, 2017 | Lund University |
| NCT02768818 | Phase 3 | Jan 1, 2016 | University of Modena and Reggio Emilia |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (19)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 2 | 0 | 1 | 2023 |
| International Center for Diarrheal Disease Research | Academic/Hospital | 2 | 1 | 1 | 2023 |
| University of Barcelona | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Aga Khan University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Chinese University of Hong Kong | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Humboldt University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Institut Pasteur | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Lund University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Perrigo | For profit | 1 | 0 | 1 | 2018 |
| Spanish Clinical Research Network | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Hamburg | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Modena and Reggio Emilia | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Munster | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Nice Sophia Antipolis | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Zambia | Academic/Hospital | 1 | 0 | 1 | 2023 |
19 organizations
Page 1 / 1